Abstract
Osteogenesis imperfecta(OI) is a heritable disease characterized by bone fragility and reduced bone mass,which can lead to multiple fractures in the patients and result in serious skeletal deformity.Genetic researches have demonstrated that OI mainly resulted from mutations of the genes encoding collagen type Ⅰ.No effective drugs for OI is avmlable previously.However,current clinical studies indicate that bisphosphonate can improve life quality of patients with OI through inhibiting osteoclast-induced bone resorption,increasing bone mineral density,decreasing bone fracture rates,and alleviating pain. Key words: Bisphosphonate; Osteogenesis imperfecta; Treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
